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ABSTRACT
Using Electrochemical Method to Study the Interaction Between DNA and a compound Known
to Have Anticancer Property
by
Alexander Kamasah
The interaction of 4-(1’-[8’-(1’’-pyrenyl)naphthyl])-2,6-diaminopyridine bis-glycamide
bishydrocholride known to have anticancer properties with deoxyribonucleic acid (DNA) had
been studied on a modified gold electrode by self-assembled monolayer using cyclic
voltammetry. K4Fe (CN) ₆ was used as a probe to obtain electrochemical information on the
electrode surface.

A bare gold (Au) electrode was modified with cysteamine and our results showed no change in
the limiting steady state current as compared to the bare Au electrode. There was a reduction in
the steady state current after the modification of the gold electrode with DNA. Immobilization
of the DNA modified gold electrode with the anticancer compound also revealed a further
reduction in the steady state current. The reduction in the steady state current is attributed to the
receptor and DNA forming a nonelectrochemical complex due to the intercalation of the receptor
and DNA on the gold electrode surface.
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CHAPTER 1
INTRODUCTION
Cellular processes such as recombination, replication, transcription, and repair involve
the interaction of DNA and protein. Quiet a large number of the intracellular processes of
living things rely on a distinctive and controlled interaction between nucleic acids and
proteins [1]. Also, many of the proteins are involved in specific sequence DNA binding in
the gene promoter region that regulates gene expression and maintenance [2]. The
preciseness and potency of these interactions are controlled by the exact structure of the
interacting molecule. Apart from these specific interactions, there are other many proteins
that bind in a non-specific way to nucleic acid and to other proteins [1]. There are certain
organic molecules that bind to these DNA with high affinity and end up influencing its gene
expression and therefore affect the cell proliferation. Apart from these specific interactions,
there are other many proteins that bind in a non-specific way to nucleic acid and to other
proteins [3].
The continuous exposure of DNA cells either by chemical or physical methods to
chemicals destroy the viability of the cells [4]. If these impaired DNA bases are not repaired,
it could cause mutation in the DNA cells [5] and can lead to the death of the cell by
obstructing DNA replication [6]. It is of great significance to study damaged DNA surface
because by doing so we would be able to identify early diagnostic of genetic deficiencies and
detection of infectious diseases. [7, 8]. Quite a number of methods have been used to study
the interaction between a DNA surface and a protein molecule some of which includes UV
spectroscopy, electrochemical impedance spectroscopy, surface plasmon resonance,
colorimetric, and electrochemical methods [9, 10]. Among these methods electrochemical
9

methods (using cyclic voltammetry) have been found to be the most convenient to use due to
its high sensitivity, low cost characteristic, and compatibility with microarray technology.
A very useful and efficient analytical tool is therefore needed to study these interactions
between DNA and protein molecules as it would give us the opportunity to evaluate and
predict possible anticancer drugs-DNA interactions. In recent years a lot of studies on the
properties of anti-carcinogenic drugs and their interactions with DNA are becoming more
and more important in developing new cancer therapy treatment. The study of these
interactions between DNA and proteins is becoming more important due to the resemblance
of electrochemical reactions and biological reactions such as oxidation mechanism taking
place at the electrode surface and also those occurring in living organism [11].
Electroanalytical analyst has adopted a better way of studying the surface properties and
interactions between protein molecules and DNA. This involves the use of a modified
electrode because of its higher sensitivity and specificity as compared to the unmodified
electrode. The use of DNA modified electrode overcomes the limitations of other methods in
large requirement for DNA samples and they also exhibit more useful electrochemical
properties than the unmodified electrode [12].

Electrochemistry
Cyclic Voltammetry
Cyclic voltammetry (CV) is a type of electrochemical technique that involves the
potential of a stationary working electrode being changed linearly with time starting from a
potential where no electrode reaction occurs and moving to potentials where reduction or
oxidation of solute (the material being studied) occurs. Cyclic voltammetry provides a simple
correlation between experimental results and redox potential, diffusion coefficients, and rate
10

constant [13]. This type of technique is generally used to study the electrochemical properties
of an analyte in solution and the analyte needs to be redox active within the experimental
potential framework. The analyte is electrolyzed (oxidized or reduced) by placing the solution in
contact with the electrode surface and making that surface positive or negative in voltage to
enhance electron transfer. The transfer of electrons or the flow of current comes about when the
potential of the electrode which is very positive of the formal potential of the electrode (EO) and
it is adjusted negatively, then reduction begins once the potential reaches the vicinity of (EO). A
rapid increase in current occurs, as the surface concentration of the reactive species becomes
smaller. The current will increase as the potential reaches the reduction potential of the analyte
but then falls off as the concentration of the analyte is depleted close to the electrode surface.
A reversal of the potential to a more positive value causes the reduced species to be
oxidized as the current moves towards (EO). A graph of current (I) against voltage (v) can be
plotted and two measured parameters that is the ratio of the peak currents (Ipa/Ipc) and the
separation of the peak potential Epa-Epc can be obtained. [5]. An example of cyclic voltamogram
is shown in Figure1.
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Figure 1: A cyclic voltammogram for a bare gold electrode. The anodic and cathodic peak current
has been indicated by Ipa and Ipc respectively

The magnitude of the peak currents, that is Ipa and Ipc and the potential at which the various
peaks occur (Epa and Epc), are the most important parameters of cyclic voltammetry[14]. In cyclic
voltammetry, three types of electrodes are used and these are the working electrode, reference
electrode, and the auxiliary or counter electrode [15]. All the electrodes are then placed in a glass
vial that is filled with a redox probe solution and the whole system is referred to as an
electrochemical cell. A typical electrochemical cell has been illustrated in Figure 2.
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Counter electrode

Working electrode
Reference electrode

Electrolyte solution

Figure 2: A general diagram of an electrochemical cell, showing the three electrodes system
employed in cyclic voltammetry
The working electrode is the electrode in electrochemical system on which the reaction of
interest is occurring. The working electrode can either be cathodic or anodic depending on whether
the reaction on the electrode is oxidation or reduction. The counter electrode is usually made of an
inert material such as platinum wire that simply serves to conduct electricity from the signal source
through the solution to the other electrodes. The counter electrode often has a large surface area that
is much larger than that of the working electrode to ensure that the half reaction occurring at the
counter electrode can take place faster so as not to limit the process at the working electrode. The
13

reference electrode consists of a piece of silver wire that is coated with AgCl. The reference
electrode is always at a known potential; this constant potential value offers a standard against which
to measure the working electrode potential [16].
Immobilization of DNA on Gold Surfaces
Quiet a number of techniques have been postulated to explain the surface-immobilization of
DNA on electrodes and among such methods include chemical adsorption [17, 18], covalent binding
[19, 20, 21], electrostatic attraction [22, 23, 24], and co-polymerization [25]. As a result of the
unprecedented growth in the development of electrochemical DNA biosensors, it would be of great
importance to seek for new methods of surface-immobilization on gold electrode surface to improve
upon the sensitivity of a DNA biosensor.
Two ideal techniques have been found to be useful for DNA surface modification on
electrode and these are Self-assembly monolayer (SAM) and Layer by Layer method.
Self-Assembly Monolayer (SAM)
The formation of self-assembled monolayers involves the presence of a bifunctional linker
such as cysteamine that serves as a means to bind the DNA to an electrode surface. It involves a
layer of material that binds to a given surface in an ordered form due to chemical or physical forces.
The length of alkyl chains present in alkanethiols determines the rate of electron transfer processes.
Longer chains show a great resistant in electron transfer as compared to shorter alkane chains [26,
27]. Figure 3 illustrates the formation of self-assembled monolayer (SAM).
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Figure 3: An illustration of a self-assembled DNA monolayer on a gold electrode
Layer by Layer Method
The layer by layer method enables multiple layers to form on a gold electrode. This is
achieved by the immersion of gold electrode in a solution containing cysteamine. The
cysteamine forms a positive charge monolayer on the gold electrode which then makes it
possible for the negatively charged phosphate backbone of the DNA to be attached to it through
electrostatic force of attraction. Another positively charged compound can then be immobilized
as shown in Figure 4 [28].

15

Figure 4: Schematic diagram showing layer by layer assembly method
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Structure of DNA
A single strand of DNA is made up of a series of nucleotides. Nucleotides are made up
of a nitrogenous base, a phosphate group and a 5- carbon sugar (pentose). The nitrogenous base
together with the pentose is called nucleoside. There are four types of nucleotides found DNA,
differing only in the nitrogenous base, and these bases are purines: which consists of adenine (A)
and guanine (G), or pyrimidines: which also consists of thymine (T) and cytosine (C). In both
DNA and RNA one of the pyrimidines is cytosine (C), and the other important pyrimidine is
thymine (T) that is basically found in DNA and uracil (U) also found in RNA. The DNA
molecule consists of two strands that form a double helix by coiling around its axis. The strands
are antiparallel in nature and that demonstrates its 5’,3’-phosphodiester bonds moves in opposite
directions. On the outside of the double helix are negatively charged phosphate groups and the
hydrophilic regions of the pentoses. The hydrophobic regions of the bases are inside the double
helical structure of the DNA. The complementary nature of the interactions between the two
strands of a DNA helix is determined by the base present on each strand. The conformation of
the two strands creates two types of grooves called the major groove and the minor groove in
each base pair. The major and minor groove can be of different sizes depending on the
conformation of DNA and can be important structural determinants in the interactions between
DNA and proteins. The structure of DNA presents a variety of sites where ligands or small
molecules may interact to bind to the DNA. The major categories of non-covalent binding to the
DNA are ionic interactions with the phosphate backbone, hydrophobic intercalative binding with
the bases, and mixed interactions with the major or minor grooves [32]. Examples of the
various nitrogenous bases and the interaction between Adenine and Thymine are shown in
Figures 5 and 6 respectively.
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Adeninie

Guanine

Thymine

Cytosine

Uracil

Figure 5: Structures of adenine, guanine, cytosine, thymine, and Uracil

Adenine

Thymine

Figure 6: Base pairing between adenine and thymine
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In nucleic acids two types of ribose can be identified, and these are deoxy-D-ribose of the
DNA and D-ribose from RNA. The two types of ribose in DNA and RNA are five membered
cyclic rings, with the difference being the substituent at carbon 2. The two types of ribose are
shown in Figure 7.

2’Deoxy-D-Ribose (in RNA)

D-Ribose (in RNA)

Figure 7: An illustration of the two forms of ribose
DNA exist in living organisms as a pair of molecules held tightly together and they
entangle into each other to form a double helix that is stabilized by hydrogen bonding between
the nucleotide and base-stacking interactions among the aromatic bases [32]. Long chain of
nucleotides of DNA and RNA is due to the presence of covalent bond through phosphate-group
bridges that link the nucleotides together. This involves the joining together of a 5’-hydroxyl
group of one nucleotide with a 3’-hydroxyl group of the next available nucleotide [33].
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Uracil
Uracil is widely known to occur naturally as a pyrimidine derivative [34]. It is found in
ribonucleic acid RNA and it base-pairs through hydrogen bonding with adenine and takes the
place of thymine throughout the process of DNA transcription. Uracil can be converted to
thymine through methylation that has been found to improve the efficiency of DNA replication.
Uracil has the potential to bind with a ribose sugar to produce ribonucleoside uridine [35]. D.J
Brown and his group investigated on the tautomeric property of uracil and they came up with
amide-imidic acid tautomeric shift. The amide tautomer is known as the lactam structure, while
the imidic acid tautomer is also called lactim structure. The tautomeric forms of the uracil are
predominant at pH 7 and the lactam structure was found to be the most common form of uracil
[36]. The tautomeric form of uracil is shown in Figure 8.

Imide

Lactim

Figure 8: A schematic illustration of tautomers of uracil
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Uracil can undergo degradation to produce compounds such as carbon dioxide, ammonia,
and aspartate. Uracil can also undergo oxidative degradation to produce urea and maleic acid in
the presence of peroxides and Fe2+ [34]. Gishan et al. and his group had been reported to
synthesize uracil in the laboratory, the simplest of them being addition of water to cytosine to
produce uracil and ammonia [35].
C4H5N3O + H2O

C4H4N2O2 + NH3

Equation 1

The most commonly used method in synthesizing uracil involves the condensation of maleic acid
with urea in fuming sulfuric acid [36]. In recent times uracil and its derivatives had been studied
due to the role that they play during molecular recognition, more importantly uracil and thymine
had been found to have relation to human diseases and cancers [37]. Figure 9 illustrates the
various derivatives of uracil.

5-Formyluracil (5FoU)

5-Fluorouracil (5FU)

Figure 9: Structures of the derivatives of uracil
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5-Nitrouracil (5FNiU)

5-Fluorouracil (5-FU) had been found to be very useful diagnosing cancers, also uracil
and 5-formyluracil are widely known due to their ability to damage DNA bases while 5Nitrouracil (5-NiU) are also known to exhibit some antiviral properties because they are able to
inhibit thymidylate synthetase [38]. 5-Flurouracil (5-FU) has been increasingly used alone or in
combination with other various cytoxic drugs and hormones in treating some tumors such as
breast, colorectal, and gastric cancers [39]. 5-Flurouracil has been found to exhibit poor tumor
selectivity and high incidence of toxicity in the bone marrow, skin, and the central nervous
system [40-43].
Drug -DNA Interactions
The interaction of small molecules including drugs with DNA can either be specific or
non-specific. For non-specific interactions, the sequence of nucleotide is not all that important,
as far as the binding interactions are concerned. However, specific DNA-protein interactions
depend upon the sequence of bases in the DNA (orientation of the bases). These protein-DNA
interactions are normally controlled by three major forces (a) hydrogen bonding, (b) ionic
interactions, (c) other forces such as Van der Waals. The interactions of protein molecules with
DNA including drugs have generated lot of interest from biological scientist and pharmaceutical
analyst. For some years now there has been an increasing concern to understand the active
mechanisms of some anticancer drug and their carcinogenic compounds and to come up with
DNA-targeted drug. Interactions of DNA with some anticancer drugs occurs via three different
methods (a) the first being under the control of transcription factors and polymerases that drug
interacts with proteins that bind to DNA, (b) the second being small aromatic compounds that
bind to the DNA double helical structure and (c) lastly through RNA binding to the DNA double
helix that brings about suppression of the transcription activity [44].
22

A very common interaction that is observed in DNA-protein is between an arginine
residue on the protein and a guanine residue as illustrated in Figure 10. A specific combination
of several intermolecular interactions between residues of a given protein and a given DNA
sequence will ensure a particular protein only binds tightly to a particular DNA sequence to
which it is targeted. The higher the number of point’s contacts that exist between the DNA
sequence and the protein, the more specific the interaction becomes [45]. Certain antibodies or
DNA-binding molecules such as Bovine serum albumin (BSA) showed no modification of signal
with DNA monolayer. This phenomenon was attributed to the fact that no interaction was
observed between BSA and the DNA because of the repulsion between their negative charges
[46]. The overall charge of Bovine serum albumin is -18 but after methylation of the compound
under acidic conditions produces methylated BSA (me-BSA) [47] that has a positive charge of
8.5 [48]. The DNA with a negative charge is then able to bind with the me-BSA through ionic
interactions. Figure 10 illustrate how argentine residue and guanine residue interact through
hydrogen bonding.

Figure 10: An illustration of the interaction between an arginine residue and guanine residue
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Barton et al. [46] used an electrochemical assay of protein binding to a modified DNA
electrode based upon detection of disturbances in DNA base stacking. They modified the gold
surface with loosely packed DNA stands and covalently crosslinked it to a redox-active
intercalator containing the binding sites of the test protein. A considerable reduction in current
was observed in the presence of base-flipping enzyme Hhal methylase and uracil DNA
glycosylase due to charge transfer between the DNA and the protein that causes some
disturbances on the DNA strand.
Drug Used for Immobilization
4-(1’-[8’-(1’’-Pyrenyl)naphthyl])-2,6-diaminopyridine Bis-glycamide Bishydrocholride
(receptor) has been found to mimic the active site in uracil DNA glycosylase (UDG). UDG is
responsible for pulling unwanted uracil into its active site through hydrogen bonding or
during DNA repair processes. The drug has been found to bind selectively to uracil and its
derivatives and also some DNA and RNA nucleosides. The 2,6-bis(glycylamino)pyridinyl group
in the drug was found to be responsible for mimicking the amino acid residues in UDG that
participate in hydrogen bonding and also the presence of a pyrenyl group mimics the phenyl
group that undergoes

stacking interactions in the active site of UDG [49]. The drug to be

used to for immobilization is shown in Figure 11.
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Figure 11: A chemical structure of the receptor binding with uracil used in immobilization 4-(1’[8’-(1’’-pyrenyl)naphthyl])-2,6-diaminopyridine bis-glycamide bishydrocholride
Research Objective
The main aim of this research is to design, construct, and study the interaction between
DNA and (4-(1’-[8’-(1’’-pyrenyl)naphthyl])-2,6-diaminopyridine bis-glycamide
bishydrocholride) known to have anticancer properties using electrochemical technique. A
monolayer of double stranded or single stranded DNA of a particular sequence was bound to the
surface of gold electrode. Cyclic voltammetry was used to characterize the DNA monolayer on
the gold surface. After the characterization of the DNA monolayer, it was then placed in a
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solution for about 30 minutes containing the drug that had been dissolved in a buffer solution.
Again cyclic voltammetry was used to study the interaction between the modified DNA
electrode and the anticancer compound by observing the various changes in the voltammogram
and then correlating it with literature values.
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CHAPTER 2
EXPERIMENTAL PROCEDURE
List of Chemicals
All aqueous solutions were made using demineralized water. 2-aminoethanethiol
hydrochloride was obtained from Sigma Aldrich (St. Louis, MO) Calf thymus double stranded DNA
was also obtained from Sigma Aldrich (St. Louis, MO), Potassium Nitrate (KNO3) was also

obtained from Fischer Scientific (NJ, USA) and was used as supporting electrolyte. All the
chemicals, unless otherwise mentioned, were of analytical grade and were used as received.
Preparation of Electrodes
A piece of Au wire was slotted into conical shaped capillary tube that was then placed in a
heating coil in order to close one of its ends. A vacuum pump was then connected to the other open
end of the capillary tube in order to remove air trapped in the tube. An electrical connection was then
made to the gold wire by connecting a copper wire to it, after which a little amount of torr seal

epoxy was applied to the open end of the glass capillary in other to seal the tube and also provide
an electrical connection. The connection between the gold and the copper was verified using a
microscope. The gold electrodes were then polished to a mirror-like surface with aluminum slurry
on a polishing pad followed by rinsing with deionized water until the surface was smoothed and
unscratched. The surface smoothness was verified again with a microscope.

Instrumentation
Cyclic voltammetry (CV) system consisting of four components was used for the experiment.
These components were (a) electrolysis cell: that consists of the working electrode, counter electrode,
reference electrode, and the electrolytic solution. The working electrode potential was varied linearly
27

with time, while the reference electrode was maintained at a constant potential. The counter electrode
conducted electricity from the signal source to the working electrode. The electrolytic solution
served as a source of ions generation needed at the electrode during the process of oxidation and
reduction. (b) An electrical device called potentiostat that uses a dc power to generate a potential that
is determined correctly, while allowing little amount of currents to be drawn into system without
altering the voltage. (c) A current-voltage converter that measures the resulting current and (d) data
acquisition system responsible for generating the voltammogram.
Electrochemical measurements (cyclic voltammetry) were carried out in a three-electrode
system that consisted of a counter electrode made of platinum, a reference electrode, and a modified
working electrode. The electrochemical measurements were carried out in a 10 mL glass cell at
room temperature. The electrodes entered the 10 mL glass vial through holes that were created in the
vial lid cover. The real electrode area was estimated from cyclic voltammogram (CV) by integrating
the cathodic peak for the reduction of the oxide layer in 0.5 M H2SO4. The freshly prepared
electrodes were scanned until a constant voltammogram was obtained
Preparation of Cysteamine Solution
The cysteamine solution used for all the experiments were freshly prepared by dissolving
0.2840 g of 2- aminoethanethiol hydrochloride in 25 mL of ethanol solution to obtained a 0.1 M
cysteamine solution. Prior to the use of the cysteamine solution it was kept in a refrigerator.
Preparation of Redox Probe Solution
The redox probe solution used for all the experiments was freshly prepared by using an
analytical balance to weigh 0.0211 g of potassium ferrocynide and transferring it into a 50 mL
volumetric flask. This was followed by weighing again 0.5055 g of potassium nitrate serving as a
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supporting electrolyte and transferring it into the 500 mL volumetric flask containing the potassium
ferrocynide. Distilled water was used in preparing this redox probe solution.
Preparation of DNA Solution
Stock solution of 0.1 M H3PO4/ NaH2PO4 buffer solution at pH 7.0 was prepared in a 500 mL
volumetric flask and kept in the refrigerator. The prepared buffer solution was then used to prepare
the DNA solution to be used for the immobilization and this was achieved by dissolving 1 g/L of the
ds DNA in 50 mL of the buffer solution. The solution was stirred for about 2 hours until a uniform
mixture was obtained.
Cysteamine- Modified Gold Electrode

Modification of the freshly prepared electrode was done by soaking the bare gold
electrode (GE) in a 0.1 M freshly prepared cysteamine solution for 24 hours at room temperature
in other to form a monolayer of cysteamine. The cysteamine modified gold electrodes were then
thoroughly rinsed with ethanol and distilled water to remove physically adsorbed cysteamine.
The modified electrodes were then characterized by scanning it in a 1 mmol of the freshly
prepared probe solution (K4Fe (CN) ₆) using potassium nitrate (KNO3) serving as the supporting
electrolyte and also in 0.5 M H2SO4 solution.
DNA-Modified Gold Electrode
The modified cysteamine gold electrodes were then placed in the DNA solution for 24
hrs containing 0.1 M NaHPO4/H3PO4 buffer of pH 7 and then thoroughly rinsed with the
phosphate buffer solution to remove physically adsorb DNA. The modified cysteamine/DNA
electrodes were then characterized in K4Fe (CN) ₆ using Ag/AgCl as reference electrode at scan
rate 100 mV/s obtain the voltammogram.
29

Immobilization of Drug on DNA-Modified Electrode
Finally, the modified DNA gold electrodes were immersed in an aqueous solution
containing the drug solution for 30 minutes and cyclic voltammogram were obtained in 1 mmol
of k4Fe (CN) ₆ and 0.1 M KNO3 as the supporting electrolyte.
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CHAPTER 3
RESULTS AND DISCUSSION
This chapter talks about the results obtained in the form of voltammogram carried out in our
redox probe solution, sulphuric acid, cysteamine solution, DNA solution, and our drug solution. This
chapter further discusses the various changes recorded in the peak current after the modification of
the electrode.
Characterization of the Bare Gold Electrode
The fabricated gold electrodes were characterized by obtaining cyclic voltammogram in 0.5
M H2S04 using Ag/AgCl reference electrode at a scan rate of 100 mV/s as shown in Figure 12. The
oxidation of the gold produced a well defined peak at 1.18 V and cathodic peak was also observed at
0.75 V representing the reduction of the gold (Au) from +3 to 0 state. The oxidation reaction
occurring at the gold electrode surface is given by the equation
Au - 3e

Au3+

Equation 2

The cyclic voltammogram obtained after the characterization is shown Figure 12.
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Figure 12: cyclic voltammogram on a bare gold electrode scanned in 0.5 M H2S04 using Ag/AgCl

reference electrode at scan rate 100 mV/s
Further characterization of the bare gold electrodes were carried out in 1mmol K4Fe (CN) ₆
using Ag/AgCl reference electrode in a potential range from 5 V to -2 V using a scan rate of 100
mV/s. The cyclic voltammogram shown in Figure 13 shows that K4Fe (CN) ₆ species on the gold

electrode surface has been oxidized. The equation below represents the oxidation of the
ferrocyanide species on the gold electrode surface.
Fe(CN) 64 - -e

Fe(CN)63-

Equation 2

Ideally at any scan rate we expect to have a well shaped voltammogram that has a flat
plateau that demonstrates there is no presence of charging current. The shape of the
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voltammogram in Figure 13 revealed a rather big charging current that is attributed to the gap
between the glass insulation layer and the gold electrode.

Figure 13: Cyclic voltammogram obtained on a bare gold electrode scanned in 1mmol of
K4Fe (CN)₆ using Ag/AgCl reference electrode at scan rate 100 mV/s
Steps were taken to reduce the charging current by placing the electrodes vertically in a
hot liquefied wax for sometime so as to seal the gap upon drying. The electrodes were then
polished so as to remove wax that might have covered the area of interest at the tip of the
electrode. Cyclic voltammetry was carried out on the electrodes but the presence of the
charging current still persisted.
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Characterization of Cysteamine Modified Gold Electrode
The characterization of the cysteamine modified gold electrode was done by obtaining
cyclic voltammogram in 1 mmol K4Fe (CN) 6 within a potential range of -0.2 V to 0.5 V using a
scan rate of 100 mV/s. The voltammogram is shown in Figure 14. Electrochemical reaction
that occurred after the immobilization of the bare gold electrode with cysteamine, revealed
apparently no change in the magnitude limiting steady state current, compared to the bare gold
electrode although the reaction still produced a reduction Fe (CN) 64+ to Fe (CN) 63+. This
phenomenon can be attributed to the fact that cysteamine which is made up of short alkanethiol
provides an insufficient barrier to block the process of electron transfer between the electrode
surface and the probe solution. This then enables most of the redox species in solution to get
access to the gold electrode surface.

Figure14: Cyclic voltammogram obtained on a cysteamine monolayer modified gold electrode in
solution containing 1mmol K4Fe (CN) ₆ with Ag/AgCl serving as reference electrode at a scan

rate of 100 mV/s
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Characterization of DNA/ Cysteamine/ Bare Gold Electrode
The characterization of the DNA/ Cysteamine/ Bare gold electrodes was done by
obtaining cyclic voltammogram in 1 mmol K4Fe (CN)₆ as shown in the Figure 15.

Figure15: Cyclic voltammogram obtained on Bare gold electrode (A), cysteamine modified electrode
(B) and DNA modified electrode (C) in 1 mmol of K4Fe(CN)₆ at a scan rate of 100 mV/s

Figure15 clearly shows a drastic reduction in the limiting steady state current observed
after the modification of the electrode with DNA compared to those of the cysteamine and the
bare gold electrode. The obvious reduction in the limiting steady state current is attributed to the
DNA acting as a mass transfer blocking layer and thereby hindering the diffusion of ferricyanide
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species towards the electrode surface. This observation shows that the DNA has been
successfully assembled on the cysteamine gold electrode surface.
Immobilization of Drug on DNA-Modified Electrode
The modified DNA/ cysteamine/ bare gold electrode was placed into an aqueous solution
of the drug solution for about 25 minutes followed by scanning it in 1 mmol M K4Fe(CN)₆ using
Ag/AgCl as a reference electrode at scan rate 100 mV/s.
The cyclic voltammogram showed a further reduction in the limiting steady current of the
redox probe after the modified DNA electrode was immersed in the receptor solution as shown
in Figure16.

Figure 16: Cyclic voltammogram obtained on Bare Au electrode (A), Cysteamine modified (B),
DNA modified electrode, (C) and Drug modified electrode, (D) in 1 mmol K4Fe(CN)₆ at scan
rate 100 mV/s
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From the voltammogram in Figure 16, electrode (D) showed a further reduction in the
limiting steady state current after the immobilization. The reduction in the limiting steady state
current of electrode (D) can be attributed to electrostatic interaction between the DNA and the
drug (4-(1’-[8’-(1’’-Pyrenyl) naphthyl])-2, 6-diaminopyridine Bis-glycamide Bishydrocholride)
forming an inert complex that prevent the electroactive species from reaching the electrode
surface and that induces the decrease of the electrochemical response due to the receptor binding
to the DNA by intercalation. The intercalation process involves the compound finding itself
stack in between the adjacent DNA pairs. Research by Jiang et al.[49] found out that (4-(1’-[8’(1’’-pyrenyl) naphthyl])-2, 6-diaminopyridine bis-glycamide bishydrocholride) has the potential
to detect and recognized damaged DNA and bases [49].
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CHAPTER 4
CONCLUSION AND RECOMMENDATION
In this research, the electrochemical behavior of the receptor (4-(1’-[8’-(1’’-pyrenyl)
naphthyl])-2, 6-diaminopyridine bis-glycamide bishydrocholride) and its interaction with a
modified DNA was investigated using electrochemical method. All the experimental results
agreed with expectations. In summary, the following conclusions were drawn from this research:
a. A modified DNA electrode was fabricated successfully using self-assembled
monolayer method
b. Cyclic voltammetry have been used to characterized the modified electrode surface
c. The results obtained indicate that, the principal interaction mode of (4-(1’-[8’-(1’’pyrenyl) naphthyl])-2, 6-diaminopyridine bis-glycamide bishydrocholride) with DNA
is by intercalative interaction.
Because the results obtained demonstrate that cyclic voltammetry provides an efficient
method to study the mechanism of DNA interaction with a compound, it would be very useful if
the interaction can be quantified using spectrophotometry method.
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